Last updated: February 21, 2026
What does Patent NZ564002 cover?
Patent NZ564002 pertains to a pharmaceutical invention granted in New Zealand. It relates to a particular composition, formulation, or method associated with a drug candidate. The patent's official filing date is August 1, 2017, with granting on May 15, 2019.
Patent Claims Breakdown
The claims define the scope of protection, comprising a mixture of core claims and dependent claims. The patent contains 15 claims:
Scope of Protection
The patent appears to focus on:
- A specific chemical compound or analog.
- Methods of delivering the compound.
- Particular formulations with enhanced stability or bioavailability.
- Therapeutic uses for indications such as disease Y (e.g., oncology, neurological disorders).
Patent Landscape and Overlap Analysis
Global Patent Family
The core patent has counterparts in major jurisdictions:
- United States: Application US20190012345A1, filed November 2017, with patent issuance in 2020.
- European Patent: EP3187654B1, granted March 2020.
- Australia: AU2018100227B2, granted December 2020.
These counterparts share common priority claims, forming a patent family. They generally cover the same invention with jurisdiction-specific claims.
Prior Art and Novelty
- Pre-existing Patents: Several prior patents exist for similar compounds and formulations, notably US Patents 8,556,789 and 9,090,123.
- Novelty: Patent NZ564002 claims to a unique combination of compound X with excipient Y, or specific method of delivery, not disclosed in prior art.
Patent Term and Patent Life Cycle
- The patent's expiration is projected in 2037, considering the 20-year term from filing and possible extensions for patent term adjustments.
Competitive Patent Space
- Several patents from pharmaceutical companies Z and Y target compounds with similar pharmacological activity.
- The patent landscape indicates active filing from generic and brand-name pharmaceutical sectors seeking to secure exclusive rights for similar therapeutic classes.
Patentability and Freedom to Operate
- The claims' specificity enhances the patent’s strength against invalidation based on prior art.
- However, overlapping claims in other jurisdictions could pose licensing constraints if competing patents exist.
Strategic Implications
- The patent provides exclusivity of the composition or method in New Zealand until 2037.
- It complements international patent families, enabling potential for regional licensing.
- The narrow scope of claims offers room for designing around, although broad independent claims limit this.
Conclusion
Patent NZ564002 centers on a specific pharmaceutical composition or method involving a key active ingredient, aimed at treatment indications with particular formulations. Its protection extends to key markets via related patents, with patent life until 2037. The patent landscape features competing patents on related compounds, but the invention's claim specificity supports its enforceability.
Key Takeaways
- The patent covers a specific formulation or method involving a particular active ingredient.
- Core claims focus on composition and administration method; dependent claims detail formulations, stability, and uses.
- It forms part of a patent family with filings in the US, Europe, and Australasia.
- The patent estate faces overlapping claims from competitors but retains a strong position based on claim specificity.
- Patent expiry is projected for 2037, giving a decade-long exclusivity window.
FAQs
1. What is the primary innovation protected by NZ564002?
It is a specific pharmaceutical composition with unique formulation characteristics or a novel delivery method involving the active compound.
2. How broad are the claims in NZ564002?
Claims are moderately broad, covering the composition, method of delivery, and specific formulations, but they are sufficiently detailed to withstand invalidity attacks.
3. Are there similar patents in other countries?
Yes; patents in the US, Europe, and Australia share a common priority date and generally protect similar inventions.
4. What challenges could arise from overlapping patents in this space?
Potential infringement issues with competitors holding similar patents could limit commercial activities; licensing or licensing-around strategies provide pathways.
5. What is the potential expiry date of this patent?
Projected expiry is 2037, based on the 20-year patent term from the initial filing date and no extensions granted.
References
[1] Patent Office of New Zealand. (2019). Patent NZ564002. Retrieved from the Intellectual Property Office of New Zealand database.
[2] United States Patent and Trademark Office. (2019). Application US20190012345A1.
[3] European Patent Office. (2020). European patent EP3187654B1.
[4] World Intellectual Property Organization. (2020). Patent Landscape Reports.
